Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.

Malli T, Buxhofer-Ausch V, Rammer M, Erdel M, Kranewitter W, Rumpold H, Marschon R, Deutschbauer S, Simonitsch-Klupp I, Valent P, Muellner-Ammer K, Sebesta C, Birkner T, Webersinke G.

Genes Chromosomes Cancer. 2016 Jan;55(1):60-8. doi: 10.1002/gcc.22311.

PMID:
26391436
2.

Disruption of the ARID1B and ADAMTS6 loci due to a t(5;6)(q12.3;q25.3) in a patient with developmental delay.

Malli T, Duba HC, Erdel M, Marschon R, Kranewitter W, Deutschbauer S, Kralik J, Diel E, Güenther B, Mueller D, Webersinke G.

Am J Med Genet A. 2014 Dec;164A(12):3126-31. doi: 10.1002/ajmg.a.36738.

PMID:
25250687
3.

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?

Webersinke G, Kranewitter W, Deutschbauer S, Zach O, Hasenschwandtner S, Wiesinger K, Erdel M, Marschon R, Böhm A, Tschurtschenthaler G.

Blood Cancer J. 2014 Jun 27;4:e221. doi: 10.1038/bcj.2014.42. No abstract available.

4.

Single-nucleotide polymorphism array-based characterization of ring chromosome 18.

Spreiz A, Guilherme RS, Castellan C, Green A, Rittinger O, Wellek B, Utermann B, Erdel M, Fauth C, Haberlandt E, Kim CA, Kulikowski LD, Meloni VA, Utermann G, Zschocke J, Melaragno MI, Kotzot D.

J Pediatr. 2013 Oct;163(4):1174-8.e3. doi: 10.1016/j.jpeds.2013.06.005.

PMID:
23876976
5.

Combined Dup(7)(q22.1q32.2), Inv(7)(q31.31q31.33), and Ins(7;19)(q22.1;p13.2p13.2) in a 12-year-old boy with developmental delay and various dysmorphism.

Frühmesser A, Erdel M, Duba HC, Fauth C, Amberger A, Utermann G, Zschocke J, Kotzot D.

Eur J Med Genet. 2013 Jul;56(7):383-8. doi: 10.1016/j.ejmg.2013.04.003.

PMID:
23608969
6.

Effects of deletion and duplication in a patient with a 46,XX,der(7)t(7;17)(q36;p13)mat karyotype.

Frühmesser A, Haberlandt E, Judmaier W, Schinzel A, Utermann B, Erdel M, Fauth C, Utermann G, Zschocke J, Kotzot D.

Am J Med Genet A. 2012 Sep;158A(9):2239-44. doi: 10.1002/ajmg.a.35450.

PMID:
22821890
7.

Parental origin of de novo cytogenetically balanced reciprocal non-Robertsonian translocations.

Höckner M, Spreiz A, Frühmesser A, Tzschach A, Dufke A, Rittinger O, Kalscheuer V, Singer S, Erdel M, Fauth C, Grossmann V, Utermann G, Zschocke J, Kotzot D.

Cytogenet Genome Res. 2012;136(4):242-5. doi: 10.1159/000337923.

8.

Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta.

Sölder E, Böckle BC, Nguyen VA, Fürhapter C, Obexer P, Erdel M, Stössel H, Romani N, Sepp NT.

Microvasc Res. 2012 Jul;84(1):65-73. doi: 10.1016/j.mvr.2012.03.005.

PMID:
22480576
9.

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.

Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, Erdel M, Hofstetter G, Concin N, Fiegl H, Müller-Holzner E, Marth C, Altevogt P, Zeimet AG.

Oncogene. 2011 Sep 22;30(38):4038-49. doi: 10.1038/onc.2011.119.

PMID:
21516127
10.

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia.

Kralik JM, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, Wiesinger K, Erdel M, Petzer AL, Webersinke G.

Diagn Pathol. 2011 Mar 15;6:19. doi: 10.1186/1746-1596-6-19.

11.

Phenotypic variability of a deletion and duplication 6q16.1 → q21 due to a paternal balanced ins(7;6)(p15;q16.1q21).

Spreiz A, Müller D, Zotter S, Albrecht U, Baumann M, Fauth C, Erdel M, Zschocke J, Utermann G, Kotzot D.

Am J Med Genet A. 2010 Nov;152A(11):2762-7. doi: 10.1002/ajmg.a.33699.

PMID:
20954245
12.

Parental origin of apparently balanced de novo complex chromosomal rearrangements investigated by microdissection, whole genome amplification, and microsatellite-mediated haplotype analysis.

Grossmann V, Höckner M, Karmous-Benailly H, Liang D, Puttinger R, Quadrelli R, Röthlisberger B, Huber A, Wu L, Spreiz A, Fauth C, Erdel M, Zschocke J, Utermann G, Kotzot D.

Clin Genet. 2010 Dec;78(6):548-53. doi: 10.1111/j.1399-0004.2010.01419.x.

PMID:
20584030
13.

Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.

Fiegl M, Erdel M, Tinhofer I, Brychtova Y, Panovska A, Doubek M, Eigenberger K, Fonatsch C, Hopfinger G, Mühlberger H, Zabernigg A, Falkner F, Gastl G, Mayer J, Greil R; Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, in cooperation with The Czech Leukemia Study Group for Life, CELL..

Ann Oncol. 2010 Dec;21(12):2410-9. doi: 10.1093/annonc/mdq236.

PMID:
20466745
14.

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

Reimer D, Hubalek M, Riedle S, Skvortsov S, Erdel M, Concin N, Fiegl H, Müller-Holzner E, Marth C, Illmensee K, Altevogt P, Zeimet AG.

Cancer Res. 2010 Jun 1;70(11):4613-23. doi: 10.1158/0008-5472.CAN-09-3551.

15.

Parental origin and mechanism of formation of a 46,X,der(X)(pter-->q21.1::p11.4-->pter)/45,X karyotype in a woman with mild Turner syndrome.

Binkert F, Spreiz A, Höckner M, Miny P, von Dach Leu B, Erdel M, Zschocke J, Utermann G, Kotzot D.

Fertil Steril. 2010 Jun;94(1):350.e12-5. doi: 10.1016/j.fertnstert.2009.12.040.

PMID:
20117774
16.

"Essentially" pure trisomy 3q27 --> qter: further delineation of the partial trisomy 3q phenotype.

Grossmann V, Müller D, Müller W, Fresser F, Erdel M, Janecke AR, Zschocke J, Utermann G, Kotzot D.

Am J Med Genet A. 2009 Nov;149A(11):2522-6. doi: 10.1002/ajmg.a.33058.

PMID:
19842202
17.

Whole genome amplification from microdissected chromosomes.

Höckner M, Erdel M, Spreiz A, Utermann G, Kotzot D.

Cytogenet Genome Res. 2009;125(2):98-102. doi: 10.1159/000227832.

PMID:
19729911
18.

Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.

Sun WL, Köck L, Walder A, Erdel M, Kilga-Nogler S, Schennach H, Fiegl M.

Ann Hematol. 2010 Mar;89(3):327-9. doi: 10.1007/s00277-009-0802-y. No abstract available.

PMID:
19672596
19.

Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer.

Feng Y, van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B.

Blood. 2009 Jan 15;113(3):755-64. doi: 10.1182/blood-2008-06-161794.

20.

Genetic analyses in a variant of Mayer-Rokitansky-Kuster-Hauser syndrome (MURCS association).

Hofstetter G, Concin N, Marth C, Rinne T, Erdel M, Janecke A.

Wien Klin Wochenschr. 2008;120(13-14):435-9. doi: 10.1007/s00508-008-0995-4.

PMID:
18726671
Items per page

Supplemental Content

Support Center